Skip to main content

MoneyWorks4Me

Biocon informs about company statement

04 Mar 2024 Evaluate

Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Biologics Secures Canada Market Entry Date for YESAFILI®, a Proposed Biosimilar to EYLEA®’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..